ArticleOpen veterinary journal2025
Platelet-rich plasma application for the management of early-stage Canine Legg-calvé-perthes disease: A clinical case report.
Article in Open veterinary journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Legg-Calvé-Perthes disease (LCPD) is characterized by ischemic necrosis of the femoral head, primarily affecting small-breed dogs. Case Description: An 11-month-old female toy poodle presented with hindlimb lameness due to LCPD. The dog was treated with intra-articular injection of platelet-rich plasma (PRP), and clinical improvement was evaluated using lameness scoring, range of motion, thigh girth measurements, and radiographic assessment. Conclusion: PRP administration resulted in significant clinical improvement, including reduction in lameness, minimal requirement of pain relief, cessation of bone lysis, and increased muscle mass by day 44 post-treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.